The therapeutic drug monitoring market was valued at USD 1.4 billion in 2025, is projected to reach USD 2.9 billion by 2036 and is forecast to register a 7.5% CAGR between 2026 and 2036, creating an incremental opportunity of USD 1.5 billion. In 2026, blood holds 75.0% of the sample type category.